CAI — Caris Life Sciences, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 2019410 ·
Last close
$31.98
Market Cap
$9.04B
52W High
$33.65
52W Low
$14.19
ADV30
5,461,513
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 263,712,000 | 179,596,000 | 26,926,000 | -637,000 | 1,229,620,000 | 690,915,000 | 637,886,000 |
| Mar 2026 | 216,174,000 | 141,348,000 | 5,282,000 | -510,000 | 1,162,388,000 | 821,147,000 | 568,898,000 |
| Dec 2025 | 292,886,000 | 220,914,000 | 88,411,000 | 81,957,000 | 1,125,663,000 | 796,274,000 | 548,356,000 |
| Sep 2025 | 216,833,000 | 147,506,000 | 32,642,000 | 24,325,000 | 984,571,000 | 753,221,000 | 506,207,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$168,558,000
Investing CF
$-144,719,000
Financing CF
$-53,777,000
CapEx
$-44,602,000
Dividends Paid
—
Buybacks
$-21,452,000
EPS Diluted TTM
$0.36
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,549,883,000
Inventory
$123,791,000
Receivables
$116,888,000
ST Investments
$102,200,000
EBIT TTM
$151,924,000
Pretax Income TTM
$105,024,000
Interest Exp TTM
$46,900,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$989,604,992
EBITDA
$174,024,992
Free Cash Flow
$63,262,624
Enterprise Value
$6,537,653,760
Total Cash
$793,115,008
Total Debt
$452,401,984
Shares Out
282,680,695
Trailing EPS
$9.58
Book Value
$2.09
ROE
20.1%
ROA
8.8%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 812,033,000 | 45,113,000 | -68,088,000 | 1,125,663,000 | 548,356,000 | 577,307,000 | 83,155,000 |
| Dec 2024 | 412,260,000 | -257,122,000 | -281,890,000 | 343,734,000 | 2,842,572,000 | -2,498,838,000 | -245,199,000 |
| Dec 2023 | 306,128,000 | -319,551,000 | -341,415,000 | 412,900,000 | 2,557,850,000 | -2,144,950,000 | -276,100,000 |
| Dec 2022 | 258,485,000 | -315,756,000 | -320,827,000 | 717,422,000 | 2,419,535,000 | -1,702,113,000 | -285,706,000 |
TTM Snapshot
Revenues TTM
$222,535,000
NetIncome TTM
$-170,310,000
OpCashFlow TTM
$0
Assets (Latest)
$1,125,663,000
Forward EPS
$0.38
Max Pain — expiry 2026-10-16
max pain strike: $25.00 · spot: $31.98 · call oi: 2,848 · put oi: 1,122
Expected Move to 2026-10-16:
±$4.12
(12.88%) —
implied range
$27.86 –
$36.10
· ATM straddle on $30.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UHS | UNIVERSAL HEALTH SERVICES INC | $9.24B | $178.86 | — |
| ENSG | ENSIGN GROUP, INC | $10.21B | $175.18 | — |
| BTSG | BrightSpring Health Services, Inc. | $11.20B | $56.59 | — |
| DVA | DAVITA INC. | $11.39B | $178.47 | — |
| FMS | Fresenius Medical Care AG | $12.08B | $22.69 | — |
News headlines (Yahoo Finance, 1h cache)
Caris Life Sciences Coasts Past A Buy Point; Why This Texas Biotech Researcher Deserves A Look
2026-09-22 18:01 · Yahoo
Caris Life Sciences Stock Jumped 10% Yesterday. Here’s Where Shares Could Go Further in 2026.
2026-09-18 08:26 · Yahoo
Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update?
2026-09-06 10:11 · Yahoo
Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference
2026-09-05 18:11 · Yahoo
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
2026-09-02 12:30 · Yahoo
Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer
2026-08-27 12:30 · Yahoo
What’s Next For Caris Life Sciences (CAI) After 21% Jump?
2026-08-07 08:03 · Yahoo
Caris Life Sciences, ECOG-ACRIN and NRG Oncology Study Demonstrates Multimodal AI Approach to Predict Late Distant Recurrence Risk in HR+ Early Breast Cancer
2026-08-06 12:30 · Yahoo
Caris Life Sciences Inc (CAI) (Q2 2026) Earnings Call Highlights: Record Revenue and Volume ...
2026-08-06 05:05 · Yahoo
Caris Life Sciences Q2 Earnings Call Highlights
2026-08-05 23:04 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.